Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Effect of simvastatin/ezetimibe 10/10 mg versus simvastatin 40 mg on serum vitamin D levels.
Liberopoulos EN, Makariou SE, Moutzouri E, Kostapanos MS, Challa A, Elisaf M.
J Cardiovasc Pharmacol Ther. 2013 May;18(3):229-33. doi: 10.1177/1074248412470513. Epub 2013 Jan 2.
Related citations
Inflammatory biomarkers and cardiovascular risk assessment. Current knowledge and future perspectives.
Moutzouri E, Tsimihodimos V, Tselepis AD.
Curr Pharm Des. 2013;19(21):3827-40.
Effects of manidipine plus rosuvastatin versus olmesartan plus rosuvastatin on markers of insulin resistance in patients with impaired fasting glucose, hypertension, and mixed dyslipidemia.
Liberopoulos EN, Moutzouri E, Rizos CV, Barkas F, Liamis G, Elisaf MS.
J Cardiovasc Pharmacol Ther. 2013 Mar;18(2):113-8. doi: 10.1177/1074248412463611. Epub 2012 Oct 31.
Effect of simvastatin or its combination with ezetimibe on Toll-like receptor expression and lipopolysaccharide - induced cytokine production in monocytes of hypercholesterolemic patients.
Moutzouri E, Tellis CC, Rousouli K, Liberopoulos EN, Milionis HJ, Elisaf MS, Tselepis AD.
Atherosclerosis. 2012 Dec;225(2):381-7. doi: 10.1016/j.atherosclerosis.2012.08.037. Epub 2012 Sep 24.
Effects of statin monotherapy versus statin plus ezetimibe combination on serum uric acid levels.
Moutzouri E, Liberopoulos EN, Florentin M, Liamis G, Elisaf MS.
J Cardiovasc Pharmacol Ther. 2013 Jan;18(1):13-8. doi: 10.1177/1074248412444463. Epub 2012 Apr 26.
Life-threatening hypophosphataemia in a cirrhotic patient with jaundice.
Moutzouri E, Liberopoulos EN, Elisaf M.
Arch Med Sci. 2011 Aug;7(4):736-9. doi: 10.5114/aoms.2011.24148. Epub 2011 Sep 2.
Prediabetes: to treat or not to treat?
Moutzouri E, Tsimihodimos V, Rizos E, Elisaf M.
Eur J Pharmacol. 2011 Dec 15;672(1-3):9-19. doi: 10.1016/j.ejphar.2011.10.007. Epub 2011 Oct 12. Review.
Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin/ezetimibe on parameters of insulin resistance.
Moutzouri E, Liberopoulos E, Mikhailidis DP, Kostapanos MS, Kei AA, Milionis H, Elisaf M.
Int J Clin Pract. 2011 Nov;65(11):1141-8. doi: 10.1111/j.1742-1241.2011.02779.x.
Add-on-Statin Extended Release Nicotinic Acid/Laropiprant but Not the Switch to High-Dose Rosuvastatin Lowers Blood Pressure: An Open-Label Randomized Study.
Kei A, Elisaf M, Moutzouri E, Tsiara S, Liberopoulos E.
Int J Hypertens. 2011;2011:830434. doi: 10.4061/2011/830434. Epub 2011 May 15.
Pharmaceutical Modulation of the Renin Angiotensin Aldosterone System for Stroke Prevention: A Review of Experimental and Clinical Evidence.
Moutzouri E, Ntaios G, Elisaf M, Milionis HJ.
CNS Spectr. 2010 Nov 1. doi:pii: Moutzouri. [Epub ahead of print]
The effect of simvastatin alone versus simvastatin plus ezetimibe on the concentration of small dense low-density lipoprotein cholesterol in subjects with primary hypercholesterolemia.
Florentin M, Liberopoulos EN, Moutzouri E, Rizos CV, Tselepis AD, Elisaf MS.
Curr Med Res Opin. 2011 Mar;27(3):685-92. doi: 10.1185/03007995.2010.546394. Epub 2011 Jan 27.
Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid.
Moutzouri E, Kei A, Elisaf MS, Milionis HJ.
Vasc Health Risk Manag. 2010 Aug 9;6:525-39. Review.
Hypocholesterolemia.
Moutzouri E, Elisaf M, Liberopoulos EN.
Curr Vasc Pharmacol. 2011 Mar;9(2):200-12.
Aliskiren, a direct renin inhibitor, in clinical practice: a new approach in the treatment of hypertension.
Moutzouri E, Florentin M, Elisaf MS, Mikhailidis DP, Liberopoulos EN.
Curr Vasc Pharmacol. 2010 May;8(3):344-62. Review.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on